| Trial ID: | L5759 |
| Source ID: | NCT00313937
|
| Associated Drug: |
Insulin Glargine
|
| Title: |
SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 1
|
| Interventions: |
DRUG: Insulin glargine
|
| Outcome Measures: |
Primary: Difference of change of blood glucose between patients on Insulin glargine and NPH insulin., between 7:00 am and 11:00 am |
|
| Sponsor/Collaborators: |
Sponsor: Sanofi
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
91
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2001-11
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2009-12-07
|
| Locations: |
Sanofi-Aventis, Berlin, Germany
|
| URL: |
https://clinicaltrials.gov/show/NCT00313937
|
